Julia Lainster

Julia Lainster

HealthTech Solutions Expert
Julia Lainster is an expert in Healthtech with a focus on electronic health records, interoperability standards, and cybersecurity. Her content is geared toward industry leaders and organizations seeking to leverage technology to improve efficiency, accuracy, and security in healthcare delivery. Julia aims to drive digital transformation and innovation in Healthtech.
Reskilling Crucial for Ireland’s Biopharma Amid Technological Growth
Management & Regulatory Reskilling Crucial for Ireland’s Biopharma Amid Technological Growth

Ireland’s biopharma industry stands as an indispensable pillar of the nation’s economy, evidencing significant contributions and future growth potential. In 2022 alone, the sector accounted for 32% of the country's industrial exports, amassing over €42 billion, and directly employed nearly 50,0

Seelos, U.S. Army Partner on SLS-002 for Breakthrough PTSD Treatment
Research & Development Seelos, U.S. Army Partner on SLS-002 for Breakthrough PTSD Treatment

Seelos Therapeutics, Inc. (NASDAQ: SEEL), a clinical-stage biopharmaceutical company, has reached a significant milestone in the development of treatments for post-traumatic stress disorder (PTSD). The company recently announced a Material Transfer Agreement (MTA) with the U.S. Army Medical

Biopharmaceutical Contract Manufacturing Market to Surge by 2032
Management & Regulatory Biopharmaceutical Contract Manufacturing Market to Surge by 2032

The global biopharmaceutical contract manufacturing market is anticipated to experience significant growth from 2024 to 2032. This market's expansion is driven by continuous technological innovations, increased research and development (R&D) investments, and strategic collaborations among

How Will AI Transform the Future of Biomanufacturing Processes?
Biotech & Bioprocessing How Will AI Transform the Future of Biomanufacturing Processes?

Biomanufacturing, the engineering of biological materials for products like pharmaceuticals, is poised for radical change. Historically reliant on specialized labor and manual processes, the sector is now at the cusp of a technological revolution powered by artificial intelligence (AI) and machine

Eli Lilly Expands Irish Facilities to Boost Global Drug Production
Management & Regulatory Eli Lilly Expands Irish Facilities to Boost Global Drug Production

Eli Lilly has announced substantial investments to expand its manufacturing capabilities in Ireland, with over $1 billion allocated to its Limerick facility and $800 million to its site in Kinsale. These expansions aim to significantly boost production capacities for essential biologic active

How Will Richter BioLogics' New Facility Transform Biopharmaceuticals?
Management & Regulatory How Will Richter BioLogics' New Facility Transform Biopharmaceuticals?

The launch of Richter BioLogics' state-of-the-art biopharmaceutical Current Good Manufacturing Practice (cGMP) facility in Bovenau, Germany marks a significant milestone for the company and the industry at large. Positioned as a forefront leader in advanced biopharmaceutical production, the

Are Zenas Biopharma and Biren Technology Leading the IPO Market Revival?
Management & Regulatory Are Zenas Biopharma and Biren Technology Leading the IPO Market Revival?

The IPO market has faced significant turmoil over the past few years, with many companies postponing or canceling their public offering plans due to weak market conditions. However, recent developments indicate a promising shift. Companies like Zenas Biopharma and Biren Technology are making

Sanofi Boosts Beyfortus Output for RSV Season with FDA Approval
Management & Regulatory Sanofi Boosts Beyfortus Output for RSV Season with FDA Approval

Sanofi is gearing up to address the rising demand for its respiratory syncytial virus (RSV) antibody drug, Beyfortus, by leveraging a recently approved manufacturing line. The company's proactive measures aim to ensure that there is no repeat of last year's shortages, which created

iTeos’ Belrestotug and Jemperli Combo Shows Promise in Lung Cancer Trial
Research & Development iTeos’ Belrestotug and Jemperli Combo Shows Promise in Lung Cancer Trial

The world of cancer treatment is ever-evolving, and recent developments have brought a glimmer of hope for those battling non-small cell lung cancer (NSCLC). iTeos Therapeutics has unveiled promising results from a mid-stage clinical trial examining the efficacy of combining their drug,

Can Centessa's New Drug Revolutionize Sleep Disorder Treatments?
Research & Development Can Centessa's New Drug Revolutionize Sleep Disorder Treatments?

Sleep disorders are a growing public health concern, impacting millions of individuals worldwide. Addressing these disorders effectively has long been a challenge for pharmaceutical companies. Enter Centessa Pharmaceuticals, a London-based biotechnology company that has made headlines with its

Loading
Latest Articles

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later